Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
---|
09/18/2012 | CA2569554C Bacteriophages that infect bacillus bacteria (anthrax) |
09/18/2012 | CA2499396C An infrared measuring apparatus and method for on-line application in manufacturing processes |
09/18/2012 | CA2434694C Detection and quantification of cripto-1 |
09/18/2012 | CA2374385C Detection of hiv-1 by nucleic acid amplification |
09/18/2012 | CA2369812C Mink-related genes, formation of potassium channels and association with cardiac arrhythmia |
09/18/2012 | CA2294962C Nucleic acid sequence analysis |
09/18/2012 | CA2279554C Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
09/18/2012 | CA2272051C Bovine lactation associated immunotropic protein (cd14), encoding gene and application in b cell activation |
09/17/2012 | CA2766436A1 A method for obtaining information on food stuff in or for a cooking process |
09/13/2012 | WO2012122540A1 Aptamers for clostridium difficile diagnostics |
09/13/2012 | WO2012122536A2 Systems and methods for high-throughput detection of an analyte in a sample |
09/13/2012 | WO2012122453A1 Kruppel-like factor 10 (klf10) as a biomarker of endothelial progenitor cell dysfunction |
09/13/2012 | WO2012122379A2 Microfluidic cytochemical staining system |
09/13/2012 | WO2012122374A2 Non-invasive methods for diagnosing chronic organ transplant rejection |
09/13/2012 | WO2012122372A2 Methods of detecting antibodies specific for denatured hla antigents |
09/13/2012 | WO2012122302A2 Methods, apparatuses, and systems for detecting and quantifying phosphoproteins |
09/13/2012 | WO2012122242A2 Compositions and methods for determining risk of a cardiovascular occlusive event |
09/13/2012 | WO2012122236A2 Method and system to detect and diagnose alzheimer's disease |
09/13/2012 | WO2012122228A2 Biomarkers of chronic obstructive pulmonary disease |
09/13/2012 | WO2012122121A2 Signal amplification for immunoassays by use of avidin-biotin linkages |
09/13/2012 | WO2012122094A2 Biomarkers of cardiac ischemia |
09/13/2012 | WO2012122024A2 Screening method for identifying patients at risk of drug induced liver injury |
09/13/2012 | WO2012122015A2 Selective inhibitors of tumor-initiating cells |
09/13/2012 | WO2012121998A1 Blood collection device containing lysophospholipase inhibitor |
09/13/2012 | WO2012121978A2 Biomarkers for the diagnosis of lacunar stroke |
09/13/2012 | WO2012121911A2 Cd16a reporter assay for evaluation of adcc potential of biologics |
09/13/2012 | WO2012121756A1 Apparatus and methods for performing optical nanopore detection or sequencing |
09/13/2012 | WO2012121746A2 Imaging beta cell mass |
09/13/2012 | WO2012121662A1 Novel pharmaceutical combinations and methods for treating cancer |
09/13/2012 | WO2012121594A1 Methods and means for monitoring disruption of tissue homeostasis in the total body |
09/13/2012 | WO2012121429A1 Method for cancer cell biomarker identification, and an nmd-irrelevant cancer cell biomarker identified by means of the method |
09/13/2012 | WO2012121396A1 Fluorescent probe and use thereof |
09/13/2012 | WO2012121392A1 Azophosphorus compound and azole compound library and method for producing same |
09/13/2012 | WO2012121324A1 Method for selecting effective group of cancer treatments combining use of three agents of taxane-based anticancer agent, platinum complex-based anticancer agent, and pyrimidine fluoride-based anticancer agent |
09/13/2012 | WO2012121310A1 Bead sealing method, method for detecting target molecule, array, kit, and target molecule detection device |
09/13/2012 | WO2012121281A1 Fuel physical property determination method and fuel physical property determination device |
09/13/2012 | WO2012121266A1 Method for evaluating progression level of diabetic disease |
09/13/2012 | WO2012121260A1 Body worn device, and device and method for measuring biological gas |
09/13/2012 | WO2012121229A1 Microorganism detection sensor and process for manufacturing same |
09/13/2012 | WO2012121225A1 Nucleic acid detection method, and device and kit for use in same |
09/13/2012 | WO2012121178A1 Tumor angiogenesis inhibitor |
09/13/2012 | WO2012120874A1 Detection method and detection device |
09/13/2012 | WO2012120829A1 Biological sample measurement apparatus |
09/13/2012 | WO2012120812A1 Absorbent pad |
09/13/2012 | WO2012120518A1 Compositions and methods for diagnosing and treating phenylketonuria (pku) |
09/13/2012 | WO2012120437A1 Method to identify liver toxicity using metabolite profiles |
09/13/2012 | WO2012120424A1 Microfluidic system for controlling a concentration profile of molecules capable of stimulating a target |
09/13/2012 | WO2012120301A1 Evaluation of therapeutic agent |
09/13/2012 | WO2012120293A1 Biosensor comprising an oxidase enzyme and a hydrogen peroxide indicator means |
09/13/2012 | WO2012120288A2 Method, array and use thereof |
09/13/2012 | WO2012120279A1 Improvements to matrix assisted laser desorption ionisation mass spectrometry imaging (maldi-msi) |
09/13/2012 | WO2012120266A1 Sensor apparatus and use thereof |
09/13/2012 | WO2012120171A1 Device and method for monitoring samples |
09/13/2012 | WO2012120170A1 Method for determining alzheimer's disease by detection of glycoproteins carrying the hnk-1 glycoepitope |
09/13/2012 | WO2012120150A1 Method for detection and quantification of target biomolecules |
09/13/2012 | WO2012120140A1 A portable sampling device and method for sampling drug substances from exhaled breath |
09/13/2012 | WO2012120130A1 Methods to characterize patients suffering from hemolysis |
09/13/2012 | WO2012120129A1 Methods and pharmaceutical composition for the treatment of infectious diseases |
09/13/2012 | WO2012120124A1 Factor xii inhibitors for the treatment of silent brain ischemia and ischemia of other organs |
09/13/2012 | WO2012120038A2 Methods for diagnosing and/or treating sterility |
09/13/2012 | WO2012119992A1 Apparatus and method for examining sample liquids |
09/13/2012 | WO2012119986A1 Modulators of slc22a7 |
09/13/2012 | WO2012119983A1 Treatment for ige-mediated disease |
09/13/2012 | WO2012119888A1 Submersible fluorometer |
09/13/2012 | WO2012119724A1 Method for the determination of polysorbate |
09/13/2012 | WO2012102779A3 Devices, systems, and methods for extracting a material from a material sample |
09/13/2012 | WO2012097304A3 Treponema pallidum triplet antigen |
09/13/2012 | WO2012097152A3 Methods and systems for predictive modeling of hiv-1 replication capacity |
09/13/2012 | WO2012088330A3 Devices, systems, and methods for fecal analysis |
09/13/2012 | WO2012082470A3 The use anti-cxcl16 and anti-cxcr6 antibodies for the treatment or detecting cancer |
09/13/2012 | WO2012075046A9 Assays and biomarkers for lrrk2 |
09/13/2012 | WO2012074870A3 Fish sexual characteristic determination using peptide hormones |
09/13/2012 | WO2012061904A8 Histone protein ubiquitination as a cancer biomarker |
09/13/2012 | WO2012025077A3 Method for the fast serological diagnosis of a salmonella subtype |
09/13/2012 | WO2011151467A3 Water distribution system comprising a device for measuring the value of at least one parameter representative of the water quality |
09/13/2012 | WO2011067450A8 Covalently biofunctionalized supports |
09/13/2012 | WO2011044125A8 A method for diagnosing primary biliary cirrhosis (pbc) using novel autoantigens |
09/13/2012 | WO2006132446A9 Method of manufacturing probe-immobilized carrier |
09/13/2012 | US20120233714 Non-human mammalian animal model for type 2 diabetes |
09/13/2012 | US20120233713 Methods and systems for inducible ablation of neural cells |
09/13/2012 | US20120232805 Computerized Amino Acid Composition Enumeration |
09/13/2012 | US20120232425 Method and apparatus for penetrating tissue |
09/13/2012 | US20120232121 Use of sarcoplasmic ca2+-atpase type 2 protein for diagnosing and treating learning or mental disorders |
09/13/2012 | US20120232107 Non-peptide antagonists of gastrin releasing peptide |
09/13/2012 | US20120232098 Methods of predicting and treating adverse cardiac events |
09/13/2012 | US20120232049 Pyridine or pyrimidine derivative having excellent cell growth inhibition effect and excellent anti-tumor effect on cell strain having amplification of hgfr gene |
09/13/2012 | US20120232016 Method and system to detect and diagnose alzheimer's disease |
09/13/2012 | US20120231552 Device for a test strip holder, method and arrangement |
09/13/2012 | US20120231551 Methods and Compositions to Detect Nucleic Acids in a Biological Sample |
09/13/2012 | US20120231548 Breath ketone detector |
09/13/2012 | US20120231504 Multiuse reactors and related methods |
09/13/2012 | US20120231488 Fluid sample collection device |
09/13/2012 | US20120231482 Method, kit or diagnostic for the detection of reagents which induce altered contractility |
09/13/2012 | US20120231481 Methods of evaluating baff |
09/13/2012 | US20120231480 Materials and methods for the differential diagnosis of pacreatic lesions |
09/13/2012 | US20120231479 Combination methods of diagnosing cancer in a patient |
09/13/2012 | US20120231478 Tivozanib response prediction |
09/13/2012 | US20120231477 Blood Biomarkers for Bone Fracture and Cartilage Injury |
09/13/2012 | US20120231476 Methods and compositions for diagnosis and prognosis of renal injury and renal failure |
09/13/2012 | US20120231475 Immunoassay for determining the release of neurotensin into the circulation |